153.35k followers • 19 symbols Watchlist by Yahoo Finance
Follow this list to discover and track the stock of publicly traded companies with exposure to cannabis
Curated by Yahoo Finance
Global spending on legal cannabis worldwide will hit $57 billion in a decade, according to Arcview Market Research and BDS Analytics. Driven by the legalization of recreational and medical cannabis and the increasing demand for both, legal cannabis revenue in the U.S. is projected to hit $23.4 billion by 2022. Yahoo Finance is now tracking the major players in the cannabis industry.How do we pick these stocks?
This is a curated list, powered by Yahoo Finance’s algorithm and intelligence from our millions of users as well as the Yahoo Finance editorial team. The list covers companies in horticulture, pharmaceutical research and ancillary businesses. We will continue to add names as corporations invest and pivot into the space.How are these weighted?
The stocks on this watchlist are weighted equally at the time they were added.
To learn what every company on this list is doing that involves cannabis, read this story.
|Watchlist||Change Today||1 Month Return||1 Year Return||Total Return|
|Symbol||Company Name||Last Price||Change||% Change||Market Time||Volume||Avg Vol (3 month)||Market Cap|
|ABBV||AbbVie Inc.||107.73||-0.35||-0.32%||4:03 p.m. EDT||14.17M||7.01M||190.27B|
|BUD||Anheuser-Busch InBev SA/NV||57.96||+0.57||+0.99%||4:00 p.m. EDT||3.04M||1.49M||114.90B|
|MO||Altria Group, Inc.||48.61||-0.18||-0.37%||4:05 p.m. EDT||11.34M||6.27M||90.38B|
|TAP||Molson Coors Beverage Company||45.8||-0.58||-1.25%||4:05 p.m. EDT||3.05M||1.61M||9.94B|
|SMG||The Scotts Miracle-Gro Company||142.31||-1.08||-0.75%||4:00 p.m. EDT||1.05M||407.26k||7.93B|
|WEED.TO||Canopy Growth Corporation||18.72||-0.09||-0.48%||4:00 p.m. EDT||2.10M||984.44k||7.17B|
|CGC||Canopy Growth Corporation||14.71||-0.12||-0.81%||4:00 p.m. EDT||2.61M||3.09M||5.63B|
|TLRY||Tilray, Inc.||12.17||+0.16||+1.33%||4:00 p.m. EDT||13.64M||18.24M||5.43B|
|CRON||Cronos Group Inc.||5.975||+0.05||+0.76%||4:00 p.m. EDT||1.97M||1.65M||2.22B|
|ACB||Aurora Cannabis Inc.||6.63||+0.01||+0.15%||4:00 p.m. EDT||3.19M||4.24M||1.31B|
|NBEV||NewAge, Inc.||1.39||-0.04||-2.80%||4:00 p.m. EDT||1.85M||1.09M||189.79M|
|CRBP||Corbus Pharmaceuticals Holdings, Inc.||1.02||-0.11||-9.73%||4:00 p.m. EDT||2.92M||1.68M||127.53M|
|TGOD.TO||The Green Organic Dutchman Holdings Ltd.||0.17||-||-||4:00 p.m. EDT||19.70M||1.54M||89.62M|
|TGODF||The Green Organic Dutchman Holdings Ltd.||0.142||-0.01||-7.79%||3:59 p.m. EDT||1.25M||731.28k||74.86M|
|CANN||General Cannabis Corp||0.41||-0.04||-9.09%||3:57 p.m. EDT||86.80k||91.18k||25.48M|
|MJ||ETFMG Alternative Harvest ETF||15.17||-0.03||-0.20%||4:00 p.m. EDT||853.34k||809.23k||-|
The U.S. Food and Drug Administration recently announced restrictions on JAK inhibitors that hurt AbbVie's (NYSE: ABBV) prospects for autoimmune disease drug Rinvoq. AbbVie stock sank more than 10% after the FDA's decision. In this Motley Fool Live video recorded on Sept. 8, Motley Fool contributors Keith Speights and Brian Orelli discuss whether or not AbbVie stock is now a bad news buy.
Whether the news is good or bad, you can take advantage of it if you understand why you're involved in a stock in the first place.
With yields ranging from 7.4% to 10.2%, these ultra-high-yield stocks can pad investors' pocketbooks.